HK Connect Ideas: Nine Weeks of Inflows, Sino Biopharm, Yadea, Anta, Aoyuan (2019-07-12)
In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...
506 Views
HK Connect Ideas: Eight Weeks of Inflows, Sinoma, Sino Biopharm, Meituan/Xiaomi (2019-07-05)
In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...
476 Views
Hansoh Pharma IPO: Valuation Reasonable for the Trade-Offs
Hansoh Pharmaceutical (3692 HK) claims to be one of the few R&D driven Chinese pharmaceutical companies. It announced its IPO price range of...
726 Views
Hansoh Pharma (翰森制药) IPO: Strong Cornerstone Line-Up, Upside at Low End
Hansoh Pharma, the largest pharmaceutical listing in Hong Kong this year, launched its book building today. In our previous insights (links...
864 Views
Hansoh Pharma (翰森制药) IPO: Thoughts on Valuation
Hansoh Pharma has started pre-marketing its IPO to raise USD 1bn in its IPO. In our previous insights, we covered the company's major products and...
735 Views